CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 8-K Event Delisting notice
- 8-K Event Exit or restructuring costs
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Executive or director change
Page 3 of 5 · 100 filings